Zearalenone Antibody Market Size, Share & Trends Analysis Report, By Type (Polyclonal, Monoclonal); By Application (Enzyme Linked Immunosorbent Assay, Immunocytochemistry, Immunofluorescence & Others), By Region, Forecasts, 2024-2031

Report Id: 2591 Pages: 170 Published: 22 July 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031 at an 18.7% CAGR during the forecast period for 2024-2031.

zearalenone

Zearalenone antibodies can detect and bind to the mycotoxin zearalenone that fusarium produces. Several different Assays and diagnostic tests use the antibody to identify and quantify zearalenone in food and feed samples. This helps to ensure that agricultural and food safety standards and regulatory compliance are met. A growing number of people worldwide are becoming increasingly concerned about the quality and safety of food, pushing up the need for zearalenone antibodies. As a result of technological improvements in immunoassay methods, the performance and accuracy of detection have improved, which has contributed to the expansion of the market. Increased investments in research and development and agricultural initiatives are known to impact the demand for zearalenone antibodies. Additionally, technological advances in zearalenone antibodies increase the adoption of zearalenone antibody-based tests and support ongoing research and development, driving market growth and ensuring high food safety standards.

However, the market growth is hampered by the accessibility and affordability of zearalenone antibodies, which can hinder rising concerns about food safety, strict regulations, and high costs. The market for zearalenone antibodies was temporarily slowed because of the COVID-19 pandemic’s impact on research and supply chains. Interest and investment have been rekindled during the pandemic due to the increased emphasis on food safety and health. Zearalenone antibodies further propelled market expansion and are in great demand because developments in antibody production technology, rising research funding, and technological improvements are boosting the zearalenone antibody market by improving detection accuracy and efficiency, which in turn ensures compliance with security criteria and safeguarding public health.

Competitive Landscape

Some of the Major Key Players in the Zearalenone Antibody Market are

  • LSBio
  • Santa Cruz Biotechnology
  • Merck
  • Biorbyt
  • Proteintech Group, Inc.
  • Abcam
  • Creative Diagnostics
  • Creative Biolabs
  • Other Prominent Players

Market Segmentation:

The global zearalenone antibody market is segmented based on type and application. By type, it is divided into polyclonal and monoclonal. By application, it is divided into enzyme-linked immunosorbent assay, immunohistochemistry, immunofluorescence, and others.

Based on the Type, the Polyclonal Market Segment is Accounted as a Major Contributor to the Zearalenone Antibody Market

The polyclonal zearalenone antibody market is expected to hold a major global market share in 2023 because of its low production costs, wide binding spectrum, and ease of application. These antibodies can detect zearalenone by binding to several epitopes, which makes them more sensitive and reliable in diagnostic settings. Because of their adaptability and low cost, they are widely used for testing and monitoring food safety.

Immunohistochemistry Segment to Witness Growth at a Rapid Rate

The immunohistochemistry segment in the zearalenone antibody market is growing because immunohistochemistry is becoming increasingly important in toxicological studies and pathology, which is driving demand for zearalenone antibodies. This technique allows for the precise localization and visualization of zearalenone presence within tissue samples, which is crucial for understanding the distribution and effects of zearalenone at a cellular level and aiding research and diagnostic applications.

In the Region, the North American Zearalenone Antibody Market Holds a Significant Revenue Share

The North American global zearalenone antibody market is expected to register the highest market share in revenue in the near future. This is because the rising focus on upholding strict dietary and feed safety standards has led to the use of cutting-edge detection methods, including assays based on zearalenone antibodies. In addition, Asia Pacific is projected to grow rapidly in the global zearalenone antibody market because of the presence of important participants in the industry, and continuous research and development activities contribute to the expansion of the market. Moreover, demand for zearalenone antibodies is being driven by the region’s escalating need for foodstuff security measures and government initiatives that are helping to propel the market forward.

Recent Developments:

  • In May 2024, Merck finalized an agreement to purchase the life science firm Mirus Bio for $600 million (around €550 million). Mirus Bio, with headquarters in Madison, Wisconsin, USA, specializes in creating and selling transfection reagents. These reagents are utilized to insert DNA into cells; one example is the TransIT-VirusGEN from Mirus Bio. These chemicals are crucial when making viral vectors for gene and cell treatments.
  • In April 2024, Proteintech Genomics, a division of Proteintech Group, Inc., introduced the MultiProTM Human Fixed Cell Immune Profiling Antibody Cocktail. This new product is part of their multi-omic solutions for single-cell and spatial analysis. This cocktail contains 53 antibodies, 5 of which are isotype controls, that target proteins both inside and outside cells. Product compatibility with the pre-titrated cocktail has been established using 10x Genomics Chromium Single Cell Gene Expression Flex.

Zearalenone Antibody Market Report Scope

Report Attribute Specifications
Market Size Value In 2023 USD 11.8 Mn
Revenue Forecast In 2031 USD 45.4 Mn
Growth Rate CAGR CAGR of 18.7% from 2024 to 2031
Quantitative Units Representation of revenue in US$ Mn and CAGR from 2024 to 2031
Historic Year 2019 to 2023
Forecast Year 2024-2031
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Type, By Application and By Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea
Competitive Landscape LSBio, Santa Cruz Biotechnology, Merck, Biorbyt, Proteintech Group, Inc., Abcam, Creative Diagnostics, Creative Biolabs, along with other prominent players.
Customization Scope Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

 

Segmentation of Zearalenone Antibody Market

Zearalenone Antibody Market- By Type

  • Polyclonal
  • Monoclonal

zearalenone

Zearalenone Antibody Market- By Application

  • Enzyme-Linked Immunosorbent Assay
  • Immunohistochemistry
  • Immunofluorescence
  • Others

Zearalenone Antibody Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Zearalenone Antibody Market Snapshot

Chapter 4. Global Zearalenone Antibody Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:

5.2.1. Polyclonal Antibodies
5.2.2. Monoclonal Antibodies

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

6.2.1. Enzyme Linked Immunosorbent Assay (ELISA)
6.2.2. Immunocytochemistry
6.2.3. Immunofluorescence
6.2.4. Others

Chapter 7. Zearalenone Antibody Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America
7.1.1. North America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.1.2. North America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.1.3. North America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe
7.2.1. Europe Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.2.2. Europe Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.2.3. Europe Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.3. Asia Pacific
7.3.1. Asia Pacific Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.3.2. Asia Pacific Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.3.3. Asia Pacific Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.4. Latin America
7.4.1. Latin America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.4.2. Latin America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.4.3. Latin America Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.5. Middle East & Africa
7.5.1. Middle East & Africa Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.5.2. Middle East & Africa Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.5.3. Middle East & Africa Zearalenone Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles

8.2.1. LSBio (U.S.)
8.2.2. Santa Cruz Biotechnology (U.S.)
8.2.3. Merck (Germany)
8.2.4. Biorbyt (U.K.)
8.2.5. Abcam (U.K.)
8.2.6. Creative Diagnostics (U.S.)
8.2.7. Creative Biolabs (U.S.)
8.2.8. Other Prominent Players

Segmentation of Zearalenone Antibody Market

Zearalenone Antibody Market- By Type

  • Polyclonal
  • Monoclonal

Zearalenone Antibody Market- By Application

  • Enzyme-Linked Immunosorbent Assay
  • Immunohistochemistry
  • Immunofluorescence
  • Others

Zearalenone Antibody Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa
Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8232
Security Code field cannot be blank!

Frequently Asked Questions

The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031.

The Zearalenone Antibody Market is expected to grow at an 18.7% CAGR during the forecast period for 2024-2031.

LSBio, Santa Cruz Biotechnology, Merck, Biorbyt, Proteintech Group, Inc., Abcam, Creative Diagnostics, Creative Biolabs, along with other prominent pl
Get Sample Report Enquiry Before Buying